BioStem Technologies, Inc. (BSEM) Return on equity 2024–2025
BioStem Technologies, Inc. (BSEM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-16.8%FY2025 · since FY2024: 77.5% → -16.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.8% | -94.3 pp |
| FY2024 | 77.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BSEM financial trends
BSEM RevenueBSEM Net incomeBSEM Net marginBSEM Gross profitBSEM Gross marginBSEM Operating incomeBSEM Operating marginBSEM Operating cash flowBSEM Free cash flowBSEM Capital expendituresBSEM Stock buybacksBSEM Dividends paidBSEM Total assetsBSEM Total liabilitiesBSEM Shareholders’ equityBSEM overview →